These effects of CHOP on the viability and apoptosis of DLBCL cells could be enhanced by silencing AURKA via suppressing β-Catenin and RAS-ERK1/2 pathway. This evidence concerns the gene MAPK3 and diffuse large B-cell lymphoma.